Internal Medicine, Rheumatology · Hermitage, PA
NPI
1598739104
Since 2006
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
2500 Highland Rd, 101
Hermitage, PA, 16148
Phone (724) 588-1082
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.9M
204,838 services
Medicare patients, 2024
390
Average age 72
Drug cost, 2024
$4.8M
7,707 prescriptions
Company payments, 2025
$4,219
From 17 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Farooq Hassan was code J0717 (injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered)), 129,600 times for 35 patients. In total Farooq Hassan billed 204,838 services in 45 codes, and Medicare paid $1.9M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2012-09-19.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 129,600 | 35 | $3.62 | $469K |
| J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | Office | 22,100 | 35 | $33.81 | $747K |
| J7328 Hyaluronan or derivative, gelsyn-3, for intra-articular injection, 0.1 mg | Office | 11,088 | 13 | $0.43 | $4,727 |
| J0897 Injection, denosumab, 1 mg | Office | 9,960 | 114 | $20.62 | $205K |
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 2,881 | 64 | $0.10 | $294 |
| 86235 Immunoassay | Office | 1,197 | 169 | $17.57 | $21K |
| 99214 Office E&M - Established | Office | 1,072 | 359 | $85.57 | $92K |
| 96401 Chemotherapy Administration | Office | 642 | 35 | $51.58 | $33K |
| 86146 Immunoassay | Office | 417 | 138 | $24.77 | $10K |
| 86147 Immunoassay | Office | 417 | 138 | $24.77 | $10K |
| 96413 Chemotherapy Administration | Office | 409 | 57 | $93.06 | $38K |
| 83516 Immunoassay | Office | 382 | 190 | $11.24 | $4,295 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 276 | 214 | $12.41 | $3,425 |
| 86431 Immunoassay | Office | 190 | 189 | $5.56 | $1,056 |
| 86200 Immunoassay | Office | 189 | 188 | $12.63 | $2,386 |
By year: 2022 $1.7M for 159,646 services; 2023 $1.8M for 194,436 services; 2024 $1.9M for 204,838 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 86235 Immunoassay | 1,197 | 169 | $17.57 | $21K |
| 86146 Immunoassay | 417 | 138 | $24.77 | $10K |
| 86147 Immunoassay | 417 | 138 | $24.77 | $10K |
| 83516 Immunoassay | 382 | 190 | $11.24 | $4,295 |
| 86431 Immunoassay | 190 | 189 | $5.56 | $1,056 |
| 86200 Immunoassay | 189 | 188 | $12.63 | $2,386 |
| 86376 Immunoassay | 185 | 184 | $14.19 | $2,625 |
| 82306 Clinical Chemistry | 174 | 172 | $28.85 | $5,020 |
| 86225 Immunoassay | 171 | 169 | $13.47 | $2,303 |
| 86226 Immunoassay | 171 | 169 | $11.87 | $2,030 |
Medicare prescription drug claims, 2024
In 2024, the drug Farooq Hassan prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,402 prescriptions and refills. In total Farooq Hassan wrote 7,707 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,402 | 2,277 | 326 | $48K |
| Methotrexate Methotrexate Sodium | 1,307 | 2,216 | 330 | $28K |
| Duloxetine Hcl Generic | 1,084 | 1,803 | 242 | $18K |
| Prednisone Generic | 699 | 1,440 | 269 | $4,628 |
| Gabapentin Generic | 440 | 616 | 112 | $6,619 |
| Meloxicam Generic | 340 | 480 | 100 | $1,501 |
| Alendronate Sodium Generic | 240 | 435 | 72 | $1,618 |
| Pregabalin Generic | 211 | 288 | 53 | $5,477 |
| Folic Acid Generic | 191 | 539 | 68 | $1,020 |
| Orencia Abatacept/Maltose | 187 | 187 | 31 | $809K |
| Prolia Denosumab | 186 | 1,104 | 129 | $307K |
| Leflunomide Generic | 140 | 247 | 43 | $10K |
| Humira(Cf) Pen Adalimumab | 104 | 105 | 18 | $707K |
| Celecoxib Generic | 101 | 135 | 29 | $2,410 |
| Enbrel Sureclick Etanercept | 98 | 98 | 17 | $738K |
Brand drugs: - claims; generic drugs: 6,693 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Farooq Hassan $4,219 ($4,219 in general payments such as food, travel and fees) from 17 companies. The largest payer was Janssen Biotech, Inc. with $910.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 31 | $910 |
| Abbvie Inc. ABBV | 56 | $872 |
| UCB, Inc. UCB.BR | 36 | $743 |
| Amgen Inc. AMGN | 25 | $554 |
| AstraZeneca Pharmaceuticals LP AZN | 8 | $182 |
| E.R. Squibb & Sons, L.L.C. BMY | 10 | $156 |
| GlaxoSmithKline, LLC. GSK | 9 | $153 |
| Lilly USA, LLC LLY | 4 | $116 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $115 |
| Invivyd Inc IVVD | 4 | $90.57 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.